Market closed
Prices delayed by at least 15 minutes | Prices updated on 13 May 2025, 17.25 BST | Print

Live UK pricing:

Creo Medical Group PLC (CREO)

ORD GBP0.001
Sell: 10.00p|Buy: 10.50p|Change: 0.10 (0.99%)

Key ratios

Company
PER (E)Ratio-
Dividend yield (E)Percentage0.00
Price earning growth (E)Ratio-
Return on equityPercentage-
Operating marginPercentage-
Earning per share growth (E)Percentage-
Enterprise value/earnings before interest, taxes, depreciation and amortizationMultiple-
Price to tangible book valueMultiple0.88
Price/Cash flowMultiple-
Price/SalesMultiple1.21

Profitability

2020202120222023
Operating marginPercentage-2.49-1.19-1.13-0.81
Profit marginPercentage-215.46-97.75-98.90-70.45
Return on equityPercentage-27.93-36.14-43.88-39.78
Return on capital employedPercentage-0.26-0.31-0.37-0.34

Financial health

2020202120222023
Gross gearingPercentage19.6714.4023.7313.88
Dividend coverMultiple----
Interest coverMultiple-134.62-82.58-102.00-60.25
Quick ratioRatio2.742.431.072.67
Current ratioRatio3.303.101.943.83

Growth

2020202120222023
Dividend per share growthPercentage----
Normalized earnings per share growthPercentage----
Reported earnings per share growthPercentage----

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.